← SynDRA
MK-0752
SynDRA canonical compound SYN0039317 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Mechanism of action | gamma secretase inhibitor |
All known targets
- APH1A; APH1B; NCSTN; PSENEN; PSEN1
Mechanisms of action (all sources)
- gamma-secretase inhibitor
- Modulator
Cross-references
Synonyms
- MK 0752
- MK0752
- UNII-9JD9B4S53T
- cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid
- 9JD9B4S53T
- 3-((1r,4s)-4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid
- 3-(cis-4-((4-Chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid
- 3-((1r,4s)-4-(4-chlorophenylsulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid
- cc-14
- C21H21ClF2O4S
- MLS006011072
- SCHEMBL756249
- SCHEMBL756248
- SCHEMBL756247
- CHEMBL3392635
Look up MK-0752 in the interactive SynDRA portal →